Silvia Lucano‐Landeros

Author

Universidad de Guadalajara ORCID

Also Known As

S Lucano-Landeros, S. Lucano-Landeros, Silvia Lucano-Landeros, Silvia Lucano‐Landeros

Publications

584

Citations

H-Index

Concepts

All Affiliations

Universidad de Guadalajara Hospital Civil de Guadalajara Tecnológico de Monterrey

About

Silvia Lucano‐Landeros is an author at Universidad de Guadalajara specializing in apoptosis, cancer research, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	26
2	Cell Biology	1	1	26
3	Hepatology	1	1	26
4	Pathology	1	1	26
5	Pharmacology	1	1	26

Silvia Lucano‐Landeros

Publications

207

Citations

H-Index

Page 1

	Year	Citations
Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C Lucia Flores-Contreras, Ana Sandoval-Rodríguez, Mayra G. Mena-Enriquez, BMC Gastroenterology	2014	79
Controlled Clinical Trial With Pirfenidone in the Treatment of Breast Capsular Contracture Evelin Rosaira Veras-Castillo, Lázaro Cárdenas-Camarena, Iván Lyra-González, Annals of Plastic Surgery	2011	35
Pirfenidone Accelerates Wound Healing in Chronic Diabetic Foot Ulcers: A Randomized, Double-Blind Controlled Trial Luz Elena Gasca-Lozano, Silvia Lucano‐Landeros, Héctor Ruiz-Mercado, Journal of Diabetes Research	2017	31
Hepatocarcinogenesis Prevention by Pirfenidone Is PPARγ Mediated and Involves Modification of Nuclear NF-kB p65/p50 Ratio Jorge Antonio Silva-Gómez, Marina Galicia‐Moreno, Ana Sandoval-Rodríguez, International Journal of Molecular Sciences Hepatocarcinogenesis PreventionApoptosisPathologyCell DeathCox-2 Expression	2021	26
Adenoviral delivery of dominant‐negative transforming growth factor β type II receptor up‐regulates transcriptional repressor SKI‐like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats Ana Laura Márquez-Aguirre, Ana Sandoval-Rodríguez, J. González-Cuevas, The Journal of Gene Medicine	2009	25
Combinatorial gene therapy induces regression of hepatic encephalopathy Francisco Javier Gálvez-Gastélum, Jesús García‐Bañuelos, Carlos Beas‐Zárate, Gene Therapy	2010	11

Page 1